Press Release: Xolair : UK Medicines and Healthcare Products Regulatory Agency has Validated and Accepted the Marketing Authorization Application for ADL-018, a Proposed Biosimilar of Xolair (omalizumab)

PISCATAWAY, N.J.--(BUSINESS WIRE)-- Kashiv BioSciences, LLC (Kashiv or the Company) today announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has validated and accepted the marketing authorization application (MAA) for...